Nishant Kumar Jain

Nishant Kumar Jain is a highly experienced professional in the field of sterile drug product development, currently serving as a Senior Principal Scientist at Bristol Myers Squibb since November 2019. Prior roles include Senior Scientist positions at Celgene and Pfizer, where contributions involved drug product formulation and process development for biologics and the leading of formulation efforts for a cancer vaccine project. Jain has held senior scientist roles at Vaxess Technologies and conducted postdoctoral research at the University of Kansas, studying various macromolecules and their stabilization. Jain's educational background includes a PhD and M.S. in Biotechnology and Pharmaceutical Sciences from the National Institute of Pharmaceutical Education and Research, alongside a B.S. in Pharmaceutical Sciences from Dr. Harisingh Gaur University.